Results 111 to 120 of about 5,890 (202)

Comparison of the Efficacy of Infrared Heat Therapy with Cryotherapy as an Adjunct to Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

open access: yesPakistan Armed Forces Medical Journal
Objective: To compare the efficacy of infrared heat therapy with cryotherapy as an adjunct to Meglumine Antimoniate in the treatment of cutaneous leishmaniasis Study Design: Quasi-experimental study Place and duration of study: Combined Military ...
Zainab Kazam, Najia Ahmed
doaj   +1 more source

Demographic and clinical characteristics of patients with anthroponotic cutaneous leishmaniasis receiving intramuscular and intralesional meglumine antimoniate, treatment outcome associated risks.

open access: yes, 2019
Demographic and clinical characteristics of patients with anthroponotic cutaneous leishmaniasis receiving intramuscular and intralesional meglumine antimoniate, treatment outcome associated risks.
Fatemeh Sharifi (3496619)   +21 more
core   +1 more source

In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotes.

open access: yesBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 1992
1. The activity of a pentavalent antimonial drug glucantime on the growth of promastigote forms of Leishmania strains involved in South American cutaneous and mucocutaneous leishmaniasis was investigated. A marked difference in susceptibility to glucantime among four different strains and cloned lines obtained from a single strain was observed. For the
E S, Moreira, M L, Petrillo-Peixoto
openaire   +1 more source

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial. [PDF]

open access: yesPLoS Negl Trop Dis, 2023
Lago J   +8 more
europepmc   +1 more source

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial. [PDF]

open access: yesPLoS Negl Trop Dis, 2023
Lago J   +8 more
europepmc   +1 more source

Tremor and generalized mioclonus caused by meglumine antimoniate

open access: yes, 2020
Cutaneous Leishmaniasis is an endemic pathology in Peru, the first line treatment being pentavalent antimonials. Occasional antimonials as the side effect, neurological symptoms that can become incapacitating, so we must be strict in the dosage at the time of administration.
Torres-Ramírez, Luis   +4 more
openaire   +1 more source

Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia. [PDF]

open access: yesTrop Med Infect Dis, 2022
Rojas Cabrera E   +9 more
europepmc   +1 more source

Is There Any Difference in the In Situ Immune Response in Active Localized Cutaneous Leishmaniasis That Respond Well or Poorly to Meglumine Antimoniate Treatment or Spontaneously Heal? [PDF]

open access: yesMicroorganisms, 2023
Leite-Silva J   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy